Last $40.40 USD
Change Today +0.47 / 1.18%
Volume 628.5K
IPXL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Larry Hsu Ph.D.

AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 2 different industries.

See Board Relationships
65$5,079,511
As of Fiscal Year 2013

Background*

Dr. Larry Hsu, Ph.D. served as the Chief Executive Officer of Impax Laboratories Inc., since October 1, 2006 until April 29, 2014 and served as its President since December 1999 until April 29, 2014. Dr. Hsu served as the Chief Operating Officer of Impax Laboratories Inc. from December 1999 to January 2003. Dr. Hsu co-founded Impax Pharmaceuticals Inc., a subsidiary of Impax Laboratories Inc. in 1994 and served as its Chief Executive Officer, President and Chief Operating ...

Read Full Background

Corporate Headquarters*

30831 Huntwood Avenue
Hayward, California 94544

United States

Phone: 510-476-2000
Fax: 510-471-3200

Board Members Memberships*

1999-Present
Director
2015-Present
Director

Education*

PhD
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$746,235
Total Annual Compensation$746,235

Stock Options*

Restricted Stock Awards$1,671,271
All Other Compensation$72,371
Exercised Options75,000
Exercised Options Value$1,377,000
Exercisable Options667,500
Exercisable Options Value$9,741,400
Unexercisable Options367,500
Unexercisable Options Value$1,899,100
Total Value of Options$13,017,500
Total Number of Options1,110,000

Total Compensation*

Total Annual Cash Compensation$1,937,959
Total Short Term Compensation$746,235
Other Long Term Compensation$1,743,642
Total Calculated Compensation$5,079,511
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPXL:US $40.40 USD +0.47

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$720.8K
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Arthur P. Bedrosian J.D.Chief Executive Officer, Director and Chairman of Strategic Planning Committee
Lannett Company, Inc.
$539.0K
Glenn Mario Saldanha Chairman of The Board, Chief Executive Officer, Managing Director, Member of Nomination and Remuneration Committee and Member of Shareholders/Investors Grievance Committee
Glenmark Pharmaceuticals Ltd.
57.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPAX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.